1,367 results on '"Schetelig, Johannes"'
Search Results
2. How risky is a second allogeneic stem cell transplantation?
3. Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
4. Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence
5. Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
6. Chronic Lymphocytic Leukemia
7. Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial
8. Correction: Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
9. Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany
10. Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study)
11. The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT
12. Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
13. Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification
14. Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial
15. Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002
16. Shape of the art: TCR-repertoire after allogeneic hematopoietic cell transplantation
17. The Collaborative Biobank (CoBi): Donor and recipient samples & data to facilitate future research on hematopoietic cell transplantation
18. Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
19. Six-year follow-up and subgroup analyses of a phase 2 trial of venetoclax for del(17p) chronic lymphocytic leukemia
20. Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy
21. Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS Registry
22. Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML
23. UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome
24. Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles
25. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
26. Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation
27. Following Transplantation for Acute Myelogenous Leukemia, Donor KIR Cen B02 Better Protects against Relapse than KIR Cen B01.
28. Potential of TCR sequencing in graft-versus-host disease
29. Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia
30. Handling missing covariate data in clinical studies in haematology
31. Klonale Hämatopoese – Bedeutung für die Zelltherapie
32. Analysis of survival outcomes in haematopoietic cell transplant studies: Pitfalls and solutions
33. Obinutuzumab, acalabrutinib, and venetoclax, after an optional debulking with bendamustine in relapsed or refractory chronic lymphocytic leukaemia (CLL2-BAAG): a multicentre, open-label, phase 2 trial
34. Breast cancer mortality of older patients with and without recurrence analysed by novel multi-state models
35. Fascia training in patients undergoing allogeneic hematopoietic cell transplantation—a pilot study
36. Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantation
37. Long‐term outcome of 2‐year survivors after allogeneic hematopoietic cell transplantation for acute leukemia.
38. Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study
39. CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome
40. Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears
41. Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears
42. Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
43. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
44. Supplementary Tables 1 from Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study
45. Data from Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study
46. Supplementary Figure 1 from Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study
47. Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight
48. Clonal hematopoiesis and its emerging effects on cellular therapies
49. Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia
50. Allogene hämatopoetische Stammzelltransplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.